ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT03011749
Date of registration:	04/01/2017
Prospective Registration:	No
Primary sponsor:	Rigshospitalet, Denmark
Public title:	Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients
Scientific title:	Value of FLT PET/CT in Radium-223 Therapy of Patients With Metastatic Castration-resistant Prostate Cancer
Date of first enrolment:	January 2017
Target sample size:	6
Recruitment status:	Terminated
URL:	https://clinicaltrials.gov/show/NCT03011749
Study type:	Interventional
Study design:	Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Phase:	N/A

Countries of recruitment
Denmark

Contacts

Key inclusion & exclusion criteria

Inclusion Criteria:

- Metastatic castration resistant prostate cancer

- Eligible for Radium-223 therapy

- Informed consent

Exclusion Criteria:

- Inability to understand study protocol

- Extensive metastatic involvement of the axial skeleton ("superscan" on bone
scintigraphy)

Age minimum: N/A
Age maximum: N/A
Gender: Male

Health Condition(s) or Problem(s) studied

Metastatic Prostate Carcinoma

Intervention(s)

Other: FLT PET/CT

Primary Outcome(s)

Uptake of FLT in hematological bone marrow [Time Frame: 3 months]

Secondary Outcome(s)

Occurrence of hematological toxicity [Time Frame: 12 months]

Secondary ID(s)

H1603551

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.